CYP3A4-mediated Pharmacokinetic Interactions in Cancer Therapy

By  

Current Drug Metabolism, Vol. 15, Iss. 8, 2014-10 ,pp. : 808-817

Bentham Science Publishers

Access to resources Recommend Favorite

Risk Management of Simvastatin or Atorvastatin Interactions with CYP3A4 Inhibitors

By Molden Espen  

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 587-596

Adis International

Access to resources Recommend Favorite

An Evaluation of Ondansetron Binding Interactions with Human Cytochrome P450 Enzymes CYP3A4 and CYP2D6

By  

Drug Metabolism Letters, Vol. 4, Iss. 1, 2010-01 ,pp. : 25-30

Bentham Science Publishers

Access to resources Recommend Favorite

Off-label uses of trazodone: a review

By Bossini Letizia   Casolaro Ilaria   Koukouna Despoina   Cecchini Federica   Fagiolini Andrea  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1707-1717

Informa Healthcare

Access to resources Recommend Favorite

Prediction of In Vivo Drug-Drug Interactions from In Vitro Data: Factors Affecting Prototypic Drug-Drug Interactions Involving CYP2C9, CYP2D6 and CYP3A4

By Brown Hayley S.   Galetin Aleksandra   Hallifax David   Houston J. Brian  

Clinical Pharmacokinetics, Vol. 45, Iss. 10, 2006-01 ,pp. : 1035-1050

Adis International

Access to resources Recommend Favorite